Search results
Results from the Health.Zone Content Network
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England. It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products. [8]
Smith opened offices in Seoul, Silicon Valley, and Guadalajara in 2000, followed by office openings in New York in 2003 and Shanghai in 2004. In 2010, the company completed construction of an enhanced, in-house, anti-counterfeit laboratory at its headquarters. Smith relocated the laboratory to a 57,199 sq. ft. operational facility in November 2014.
In the late 1980s the business was acquired by Smith and Nephew. In June 2000, Smith and Nephew divested its consumer products division; a management buyout, led by CEO Geoff Percy and Finance Director Peter Hatherly, for £140m resulted in the formation of Accantia, owner of the Simple brand. In January 2004, a secondary buyout was completed.
Since becoming CEO in April 2011, Frenchman Olivier Bohuon has repositioned Smith and Nephew with acquisitions in advanced wound care and sports medicine, to reduce the company's dependence on the ...
By Prerna Bedi. (Reuters) -British medical equipment maker Smith+Nephew retained its annual revenue and margin forecasts on Wednesday after posting a near 3% rise in revenue in the first quarter ...
Smith & Nephew plc (NYSE: SNN) has acquired Engage Surgical, a provider of cementless unicompartmental (partial) knee systems. Engage Surgical is located in Orlando, Florida. The deal value of up ...
On 1 April 2001, the company founded an independent subsidiary, BSN Medical, as a joint venture of Beiersdorf (Hamburg) and the British-based, American-owned Smith & Nephew (London) and serves the market for surgical dressing, orthopaedics and phlebology. BSN Medical had 350 employees in Germany and 3,400 worldwide in 2004.
Bohuon was the chief executive of Smith & Nephew plc and Smith & Nephew Inc from April 2011 until May 2018. He served as the chief executive of Laboratoires Pierre Fabre from September 2010. Before that, he worked for Abbott Laboratories from 2003 to July 2010, rising to executive vice president, pharmaceutical products. [citation needed]